As of September 2024, Astellas Pharma has a market cap of $22.03B. This makes Astellas Pharma the world's 802th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $21.35B | -1.99% |
2023 | $21.79B | -15.97% |
2022 | $25.93B | 7.27% |
2021 | $24.17B | 17.35% |
2020 | $20.60B | -14.76% |
2019 | $24.17B | 33.43% |
2018 | $18.11B | -2.47% |
2017 | $18.57B | -11.49% |
2016 | $20.98B | -6.24% |
2015 | $22.38B | 2.67% |
2014 | $21.79B | 35.35% |
2013 | $16.10B | 60.77% |
2012 | $10.02B | 23.80% |
2011 | $8.09B | 1.13% |
2010 | $8.00B | -10.55% |
2009 | $8.94B | -4.68% |
2008 | $9.38B | -25.46% |
2007 | $12.59B | -9.98% |
2006 | $13.98B | 17.61% |
2005 | $11.89B | 15.29% |
2004 | $10.31B | 19.82% |
2003 | $8.61B | -3.20% |
2002 | $8.89B | -0.58% |
2001 | $8.94B | -29.96% |
2000 | $12.77B | - |